Genes and pathways downstream of telomerase in melanoma metastasis
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Recent studies have demonstrated a role for telomerase in driving tumor progression, but its mechanism of action remains unclear. Here we show that stable, ribozyme-mediated suppression of mouse telomerase RNA reduced telomerase RNA expression, telomerase activity, and telomere length, which significantly reduced tumor invasion and metastatic potential. Our studies reveal that previously unidentified effects of telomerase may mediate its tumor-promoting effects. First, reducing telomerase activity induced a more dendritic morphology, accompanied by increased melanin content and increased expression of tyrosinase, a key enzyme in melanin biosynthesis. Second, gene expression profiling revealed that telomerase targeting down-regulated expression of several glycolytic pathway genes, with a corresponding decrease in glucose consumption and lactate production. Thus, telomerase activity controls the glycolytic pathway, potentially altering the energy state of tumor cells and thereby modulating tyrosinase activity and melanin production. These studies have important implications for understanding the mechanisms by which telomerase promotes tumor invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [51]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Telomere states and cell fates
Blackburn, E. H. (2000) · Nature · doi:10.1038/35040500 · Cited by 1,377
Self-citationGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Self-citationInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Telomeres: Beginning to Understand the End
Zakian, V. A. (1995) · Science · doi:10.1126/science.270.5242.1601 · Cited by 852
Kang, S. S., Kwon, T., Kwon, D. Y., & Do, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13085 · Cited by 480
Research works printed but not linked: 3
- A. Ludwig, G. Saretzki, P. S. Holm, F. Tiemann, M. Lorenz, T. Emrich Cancer Res. 61, 3053–3061 (2001).
- S. S. Kang, T. Kwon, D. Y. Kwon, S. I. Do J. Biol. Chem. 274, 3085–3090 (1999).
- W. Zhang, M. A. Piatyszek, T. Kobayashi, E. Estey, M. Andreeff, A. B. Deisseroth, W. E. Wright, J. W. Shay Clin. Cancer Res. 2, 799–803 (1996).
Cited by
Items 101–130 of 130
Kim, H. M., & Koo, J. S. (2017) · Disease Markers · doi:10.1155/2017/6230294 · Cited by 7
“In previous studies, several genes involved in the glycolytic pathway were shown to be downregulated following TERT knockdown, suggesting that TERT directly regulates cancer cell metabolism, especially glycolysis [31, 32].”
BackgroundYuan, H., Qin, X., Yang, Q., Liu, L., Fang, Z., Fan, Y., & Xu, D. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00526-7 · Cited by 6
“Increased TERC expression not only enhances telomerase activity to lengthen telomeres, but also promotes cancer aggressiveness independently of the canonical telomerase function [54].”
BackgroundXie, X. C., Ge, L. Y., Lai, H., Qiu, H. B., Tang, F., & Qin, Y. (2016) · Balkan Medical Journal · doi:10.5152/balkanmedj.2015.151182 · Cited by 6
Genes and pathways downstream of telomerase in melanoma metastasis
Galbraith, G. M. P. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70657-9 · Cited by 6
Telomere length in relation to colour polymorphism across life stages in the tawny owl
Morosinotto, C., Bensch, S., & Karell, P. (2020) · Journal of Avian Biology · doi:10.1111/jav.02564 · Cited by 6
Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR
Katunarić, M., & Zamolo, G. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.05.021 · Cited by 5
“The telomerase level has been correlated with progression of several cancer types, including acute leukemia, breast, prostate, lung cancer and melanoma.”
BackgroundOlovnikov, Telomeres, and Telomerase. Is It Possible to Prolong a Healthy Life?
Yegorov, Y. E. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923110032 · Cited by 5
“Telomerase has also been shown to affect activity of the glycolysis genes [57], stimulate transcription of the genes associated with epithelial-mesenchymal transition (vimentin and snail1) [58].”
BackgroundSignaling Pathways Altered During the Metastatic Progression of Melanoma
Monteiro, A. C., Toricelli, M., & Jasiulionis, M. G. (2015) · InTech eBooks · doi:10.5772/59747 · Cited by 4
“Interestingly, it was also seen a regulation of genes of the glycolytic pathway, as aldolase, suggesting that telomerase can mediate its metastatic properties through activation of glycolysis in cancer [106].”
BackgroundSharma, S., Sengupta, A., & Chowdhury, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073457 · Cited by 4
Extra-Telomeric Roles of Telomeric Proteins
Ghosh, A., & Tergaonkar, V. (2012) · InTech eBooks · doi:10.5772/38661 · Cited by 3
Telomeres and Telomerase in Human Health and Disease
Lin, J., Epel, E. S., & Blackburn, E. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-74966-0_1 · Cited by 2
“…have high telomerase activity levels, partially knocking down telomerase RNA – by RNAi or ribozyme administration – rapidly caused the cells to change their properties, including gene expression profiles and morphology, even though they continued to divide (Li et al. 2005; Bagheri et al. 2006).”
BackgroundSelf-citationTelomerase and Oxidative Stress in Embryonic Stem Cells
Saretzki, G. C. (2011) · InTech eBooks · doi:10.5772/15307 · Cited by 2
Seyfried, T. N. (2012) · Wiley eBooks · doi:10.1002/9781118310311.ch12 · Cited by 2
Li, Y. (2010) · Systems biology · doi:10.1007/978-1-4419-5797-9_20 · Cited by 2
Kim, H. M., Kim, E.-S., & Koo, J. S. (2018) · PubMed · Cited by 3
Taheri, M. A., Amani, L., Nabavi, N., وزیری, ع. ز., & Khalili, A. (2022) · The Scientific Journal of Cosmointel · doi:10.61450/joci.v1i6.56 · Cited by 2
Inhibition of Telomerase with Imetelstat Causes Depletion of Cancer Stem Cells
Nitta, R. T., Go, N. F., Avilion, A. A., & Joseph, I. (2012) · Springer eBooks · doi:10.1007/978-94-007-2900-1_2 · Cited by 1
Genetic variants in telomere-maintenance genes and bladder cancer risk
Gu, C., Zhu, Y., & Ye, D. (2013) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-012-1208-1 · Cited by 1
Telomere and Telomerase in Cancer
Angayarkanni, J., Kiran, K. G., & PALANISWAMY, M. (2016) · InTech eBooks · doi:10.5772/64721 · Cited by 1
Teralı, K., & Yılmazer, A. (2016) · InTech eBooks · doi:10.5772/65762 · Cited by 1
“In harmony with the concept that metabolism is involved in the control of cancer stemness, a microarray-based gene expression profiling study elucidated that ribozyme-mediated targeting of telomerase in murine mela‐ noma cells downregulates the expression of more than a few glycolytic pathway genes such as those codin…”
BackgroundTelomerase : a prognostic marker and therapeutic target
Thakkar, D. (2010) · CLOK (University of Central Lancashire)
Interrogating telomerase activity and telomere function through in-flask template evolution
Pruitt, M. (2017) · KU ScholarWorks (The University of Kansas)
Estudio de algunos factores relacionados con la senescencia del epitelio superficial del ovario
Chuaire Noack, L. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.835
تأثیر میدان شعوری فرادرمانی بر تکثیر، فعالیت آنزیم تلومراز و طول تلومر سلولهای بنیادی مزانشیمی انسان
طاهری, م. ع., امانی, ل., نبوی, ن., وزیری, ع. ز., & خلیلی, ا. (2022) · ژورنال علمی کازمواینتل · doi:10.61450/joci.fa.v1i6.116
Olovnikov, telomeres and telomerase. is it possible to prolong a healthy life?
Yegorov, Y. E. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523110040
Telomere, DNA Damage Response, and Nanomedicine: A Triad for Cancer Treatment Innovation
Afshar, Y., Sharif, H., & Rezaei, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_486
Yuan, H., Qin, X., Yang, Q., Liu, L., Fang, Z., Fan, Y., & Xu, D. (2024) · Figshare · doi:10.6084/m9.figshare.26603479
Télomerase et destin des tumeurs neuroblastiques
Samy, M. (2010) · theses.fr (ABES) · doi:10.70675/07050b7dz1056z4e65za6f1z34cea95a398b · Cited by 2
“En revanche des études ont montré que l’inhibition de la télomérase par différentes stratégies, entraîne une différenciation terminale des mélanocytes (Bagheri et al., 2006) et un changement de la morphologie des gliomes après plusieurs semaines de cultures (Kondo et al., 1998).”
BackgroundImpact des xénobiotiques sur la progression tumorale des cellules cancéreuses humaines
Saunier, E. F. (2015) · theses.fr (ABES) · doi:10.70675/a101c5f4zbc25z48fez96a4z0bcd3339674d
Metadata
- Authors
- Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., Sagebiel, R. W., Cleaver, J. E., Haqq, C., Debs, R. J., Blackburn, E. H., & Kashani-Sabet, M.
- Affiliations
- University of California, San Francisco (US)
- California Pacific Medical Center (US)
- *Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, and Department of Dermatology, University of California, San Francisco, CA 94115;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-07-25
- Volume
- 103
- Issue
- 30
- Pages
- 11306-11311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1544082
- OpenAlex
- W1969066171
- Cited by
- 129
- References
- 35
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 16 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 10
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- National Cancer Institute (R01CA114337, R01CA096666, CA96840, CA96666, R01CA096840, CA114337)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03AR049378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- telomerase, melanoma, metastasis, tumor invasion, telomerase RNA, ribozyme knockdown, telomere length, tyrosinase, melanogenesis, glycolysis, glucose metabolism, lactic acid production, tumor cell morphology, downstream signaling pathways
- MeSH terms
- Animals, Cell Differentiation, Glucose, Lactates, Melanins, Melanoma, Melanoma, Experimental, Mice, Inbred C57BL, Neoplasm Invasiveness, Neoplasm Metastasis, Monophenol Monooxygenase, Gene Expression Regulation, Neoplastic, Telomerase, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.